参考文献

[1]Jemal A, Murray T, Samuels A, et al.Cancer statistics, 2003. CA Cancer J Clin, 2003; 53(1): 5～26
[2]Shekarriz B, Upadhyay J, Pontes JE.Salvage radical prostatectomy. Urol Clin North Am, 2001; 28(3): 545～553
[3]Grado GL, Collins JM, Kriegshauser JS, et al.Salvage brachytherapy for localized prostate cancer after radiotherapy failure. Urology, 1999; 53: 2～10
[4]Soanes WA, Gonder MJ.Use of cryosurgery in prostatic cancer. J Urol, 1968 ; 99: 793～797
[5]Gonder MJ, Soanes WA, Shulman S.Cryosurgical treatment of the prostate. Invest Urol, 1966; 3(4): 372～328
[6]Cooperberg MR, Lubeck DP, Meng MV, et al.The changing face of low-risk prostate cancer: trends in clinical presentation and primary management. J Clin Oncol, 2004; 22: 2141～2149
[7]Ellis DS.Cryosurgery as primary treatment for localized prostate cancer: a community hospital experience. Urology, 2002; 60(2 Suppl 1): 34～39
[8]De La Taille A, Benson MC, Bagiella E, et al.Cryoablation for clinically localized prostate cancer using an argon-based system: complication rates and biochemical recurrence. BJU Int, 2000; 85: 281～286.
[9]Gleason DF, Mellinger GT.Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J Urol, 1974; 111: 58～64
[10]Grossfeld GD, Latini DM, Lubeck DP, et al.Predicting disease recurrence in intermediate and high-risk patients undergoing radical prostatectomy using percent positive biopsies: results from CaPSURE. Urology, 2002; 59: 560～565
[11]Zisman A,Pantuck AJ,Cohen JK,and Belldegrun AS.Prostate
cryoablation using direct transperineal placement of ultrathin probes
through a 17-gauge brachytherapy results.Urology, 2001;58:988～993
[12]Ellis DS.Cryosurgery as primary treatment for localized prostate cancer:a community hospital experience.Urology, 2002;60(Suppl 2 A):34～39
[13]Onik G, Cobb C, Cohen J, et al.US characteristics of frozen prostate. Radiology, 1988; 168: 629～631
[14]Saliken JC, Donnelly BJ, Rewcastle JC.The evolution and state of modern technology for prostate cryosurgery. Urology, 2002; 60(2 Suppl 1): 26～33
[15]Onik G, Narayan P, Vaughan D, et al.Focal "nerve-sparing" cryosurgery for treatment of primary prostate cancer: a new approach to preserving potency. Urology, 2002; 60: 109～114
[16]Miller RJ, Cohen JK, Merlotti LA. Percutaneous transperineal cryosurgical ablation of the prostate for the primary treatment of clinical stage C adenocarcinoma of the prostate. Urology, 1994 ; 44: 170～174
[17]Bahn DK, Lee F, Solomon MH, et al.Prostate cancer: US-guided percutaneous cryoablation. Work in progress. Radiology, 1995; 194: 551～556
[18]Coogan CL, McKiel CF.Percutaneous cryoablation of the prostate: preliminary results after 95 procedures. J Urol, 1995; 154: 1813～1817
[19]Wieder J, Schmidt JD, Casola G, et al.Transrectal ultrasound-guided transperineal cryoablation in the treatment of prostate carcinoma: preliminary results. J Urol, 1995; 154(2 Pt 1): 435～441
[20]Bales GT, Williams MJ, Sinner M, et al.Short-term outcomes after cryosurgical ablation of the prostate in men with recurrent prostate carcinoma following radiation therapy. Urology, 1995; 46: 676～680
[21]Shinohara K, Connolly JA, Presti JC, Carroll PR. Cryosurgical treatment of localized prostate cancer (stages T1 to T4): preliminary results. J Urol, 1996; 156: 115～120
[22]Wake RW, Hollabaugh RS, Bond KH.Cryosurgical ablation of the prostate for localized adenocarcinoma: a preliminary experience. J Urol, 1996; 155: 1663～1666
[23]Cohen JK, Miller RJ, Rooker GM, Shuman BA.Cryosurgical ablation of the prostate: two-year prostate-specific antigen and biopsy results. Urology, 1996; 47: 395～401
[24]Pisters LL, von Eschenbach AC, Scott SM, et al.The efficacy and complications of salvage cryosurgery of the prostate. J Urol, 1997; 157: 921～925
[25]Lee F, Bahn DK, Badalament RA, et al. Cryosurgery for prostate
cancer: improved glandular ablation by use of 6 to 8 cryoprobes. Urology,
1999; 54: 135～140
[26]Gould RS.Total cryosurgery of the prostate versus standard cryosurgery versus radical prostatectomy: comparison of early results and the role of transurethral resection in cryosurgery. J Urol, 1999; 162: 1653～1657
[27]Long JP, Bahn D, Lee F, et al: Five-year retrospective, multi-institutional pooled analysis of cancer-related outcomes after cryosurgical ablation of the prostate. Urology, 2001; 57: 518～523
[28]Bahn DK, Lee F, Badalament R, et al.Targeted cryoablation of the prostate: 7-year outcomes in the primary treatment of prostate cancer. Urology, 2002; 60(2 Suppl 1): 3～11
[29]Han KR, Cohen JK, Miller RJ, et al.Treatment of organ confined prostate cancer with third generation cryosurgery: preliminary multicenter experience. J Urol, 2003; 170(4 Pt 1): 1126～1130
[30]Lam JS,Leppert JT,Koski ME,et al.Salvage cryosurgical ablation for
radiorecurrent prostate cancer using third generation cryoneedles:the
Califonia-Los Angeles experience.J Urol,2005;173:181
[31]Katz AE,Prepelica K,Masson P,et al.Salvage cryosurgical ablation of the prostate(TCAP) for patients failing radiation:10-year experience.J Urol, 2005;173:450～451
[32]Vellet AD,Saliken J,Donnely B,et al.Prostate cryosurgery:Use of MR imaging in evaluation of success and technical modification.Radiology 1997;203:653～659
[33]Chin JL, Touma N, Pautler SE, et al.Serial histopathology results of salvage cryoablation for prostate cancer after radiation failure. J Urol, 2003; 170(4 Pt 1): 1199～1202
[34]Connolly JA, Shinohara K, Presti JC Jr, Carroll PR.Should cryosurgery be considered a therapeutic option in localized prostate cancer? Urol Clin North Am, 1996; 23: 623～631
[35]Shinohara K, Rhee B, Presti JC, Carroll PR.Cryosurgical ablation of prostate cancer: patterns of cancer recurrence. J Urol, 1997; 158: 2206～2209
[36]Wong WS, Chinn DO, Chinn M, et al.Cryosurgery as a treatment for prostate carcinoma: results and complications. Cancer, 1997; 79: 963～974
[37]Prepelica KL, Okeke Z, Murphy A, Katz AE.Cryosurgical ablation of the prostate: high risk patient outcomes. Cancer, 2005; 103: 1625～1630
[38]Ghafar MA, Johnson CW, De La Taille A, et al.Salvage cryosurgery using an argon based system for locally recurrent prostate cancer after radiation therapy: the Columbia experience. J Urol, 2001; 166(4): 1333～1337
[39]Chin JL, Pautler SE, Mouraviev V, et al.Results of salvage cryoablation of the prostate after radiation: identifying predictors of treatment failure and complications. J Urol, 2001; 165(6 Pt 1): 1937～1941
[40]Bahn DK, Lee F, Silverman P, et al.Salvage cryosurgery for recurrent prostate cancer after radiation therapy: a seven-year follow-up. Clin Prostate Cancer, 2003; 2(2): 111～114
[41]Lam JS,Belidegrum AS.Salvage cryosurgery of the prostate after
radiation failure.Review in Urology, 2004;6：S27～36
[42]Cohen J. Cryosurgery of the prostate.techniques and indications. Review in Urology, 2004:6:S21～26
[43]Cox RL, Crawford ED. Complications of cryosurgical ablation of the prostate to treat localized adenocarcinoma of the prostate. Urology,1995; 45: 932～935
[44]Ahmed S, Davies J.Managing the complications of prostate cryosurgery. BJU Int, 2005; 95: 480～481
[45]Robinson JW, Donnelly BJ, Saliken JC, et al.Quality of life and sexuality of men with prostate cancer 3 years after cryosurgery. Urology, 2002; 60(2 Suppl 1): 12～18
[46]Long JP, Fallick ML, LaRock DR, Rand W.Preliminary outcomes following cryosurgical ablation of the prostate in patients with clinically localized prostate carcinoma. J Urol 1998; 159(2): 477～484.
[47]Mouravier V,Polascik TJ.Update on cryotherapy for prostate cancer in
2006.Curr Opin Urol, 2006;16:152～156
[48]Rukstalis DB, Goldknopf JL, Crowley EM, Garcia FU.Prostate
cryoablation: a scientific rationale for future modifications. Urology, 2002;
60(2 Suppl 1): 19～25
[49]Onik GM, Cohen JK, Reyes GD, et al.Transrectal ultrasound-guided percutaneous radical cryosurgical ablation of the prostate. Cancer 1993; 72: 1291～1299
[50]Barquwi A,Crawford ED.Focal therapy in prostate cancer:future trends.BIU Int, 2005;95:520～525
[51]Masson PPK,Lambert EH,McKieman JM,et al.Focal cryosurgery:encouraging health outcome for unifocal prostate cancer.J Urol, 2005;173:179
[52]Clarke DM, Baust JM, Van Buskirk RG, Baust JG.Chemo-cryo combination therapy: an adjunctive model for the treatment of prostate cancer. Cryobiology, 2001; 42: 274～285
[53]Clarke DM, Baust JM, Van Buskirk RG, Baust JG.Addition of anticancer agents enhances freezing-induced prostate cancer cell death: implications of mitochondrial involvement. Cryobiology, 2004; 49(1): 45～61
[54]Chao BH, He X, Bischof JC.Pre-treatment inflammation induced by TNF-alpha augments cryosurgical injury on human prostate cancer. Cryobiology,2004;49:10～27